1. FC 130RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3B TRIAL OF TOLVAPTAN IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): 1-YEAR DATA. (29th May 2021) Authors: Mekahli, Djalila; Guay-Woodford, Lisa; Cadnaparphornchai, Melissa; Greenbaum, Laurence A; Litwin, Mieczysław; Seeman, Tomas; Dandurand, Ann; Shi, Lily; Sikes, Kimberley; Shoaf, Susan; Schaefer, Franz Journal: Nephrology dialysis transplantation Issue: Volume 36(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗